Asia-Pacific Sleep-Wake Disorder Market Size to Reach $9.5 Billion by 2035

Asia-Pacific sleep-wake disorder market is projected to grow from $5.1 billion in 2025 and is projected to reach $9.5 billion by 2035, growing at a CAGR of 6.3% during the forecast period 2026-2035. The Asia-Pacific sleep-wake disorder market is evolving steadily as healthcare systems place greater emphasis on the identification and management of sleep-related conditions. Increasing urbanization, changing work patterns, and extended digital device usage have contributed to a rise in sleep disturbances across different age groups. Healthcare providers in several countries are expanding access to sleep clinics, diagnostic laboratories, and home-based assessment services to address growing patient demand. The market is also witnessing broader integration of wearable monitoring technologies and digital health platforms for continuous sleep tracking and remote consultation. In addition, awareness regarding the relationship between sleep disorders and long-term neurological, cardiovascular, and metabolic complications is influencing clinical attention toward earlier diagnosis and treatment intervention.

Browse the full report description of “Asia-Pacific Sleep-Wake Disorder Market Size, Share & Trends Analysis By Disorder Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Sleep-Wake Disorders, Parasomnias, Dyssomnias, and Others), By Treatment Type (Pharmacological Therapy, Behavioral Therapy, Light Therapy, Device-Based Therapy, and Others), By Diagnosis & Management Approach (Polysomnography & Sleep Studies, Actigraphy-Based Monitoring, Clinical Evaluation & Screening Tools, and Remote/Digital Sleep Monitoring Solutions), and By Application (Hospitals, Home Care Settings, and Others), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/asia-pacific-sleep-wake-disorder-market

The market is further shaped by ongoing developments in non-invasive therapeutic technologies and connected respiratory care systems designed for long-term patient management. Regional manufacturers and international medical technology companies are increasingly focusing on compact diagnostic equipment, cloud-enabled monitoring systems, and patient-centered therapy devices. Homecare settings are becoming more prominent within the treatment landscape due to convenience, accessibility, and improvements in telehealth infrastructure across several Asia-Pacific countries. At the same time, collaboration between hospitals, sleep specialists, and technology providers is supporting the adoption of integrated care approaches for chronic sleep disorders. Regulatory support for digital healthcare expansion and the gradual modernization of healthcare infrastructure are also contributing to market progression across the region.

Competitive Landscape of the Sleep-Wake Disorder Market

The key players in the sleep-wake disorder market are ResMed Inc., Fisher & Paykel Healthcare Corp. Ltd., Takeda Pharmaceutical Company Ltd., Compumedics Ltd., and Nihon Kohden Corp., among others. The competitive landscape of the Asia-Pacific sleep-wake disorder market is characterized by the presence of companies specializing in respiratory care devices, sleep diagnostics, neurological monitoring systems, and pharmaceutical therapies. Market participants are focusing on expanding home-based treatment capabilities, digital sleep assessment technologies, and connected patient monitoring platforms to address evolving clinical requirements. Ongoing investments in portable diagnostic equipment, AI-assisted therapy management, and integrated sleep care solutions are contributing to product innovation across the region. Strategic collaborations with hospitals, sleep laboratories, and healthcare providers are also supporting broader access to sleep disorder diagnosis and long-term treatment management services.

• In October 2025, Philips Japan Ltd. organized large-scale public awareness programs in Niigata and Hiroshima, focused on sleep apnea education and early diagnosis initiatives. The company collaborated with healthcare experts and regional medical organizations to strengthen awareness regarding home-based sleep testing and CPAP therapy adoption in Japan.

• In July 2025, Compumedics Limited reported strong growth in its Sleep & Neurology business segment, driven by rising adoption of Somfit and Nexus 360 sleep diagnostic platforms. The company highlighted increasing demand for SaaS-enabled sleep diagnostics and connected home sleep testing technologies across Asia-Pacific and global healthcare markets.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Disorder Type
  • By Treatment Type
  • By Diagnosis & Management Approach
  • By Application
• Competitive Landscape - ResMed Inc., Fisher & Paykel Healthcare Corp. Ltd., Takeda Pharmaceutical Company Ltd., Compumedics Ltd., and Nihon Kohden Corp.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Asia-Pacific Sleep-Wake Disorder Market Report Segment

By Disorder Type

• Insomnia
• Hypersomnia
• Sleep Apnea
• Circadian Rhythm Sleep-Wake Disorders
• Parasomnias
• Dyssomnias
• Others

By Treatment Type

• Pharmacological Therapy
• Behavioral Therapy
• Light Therapy
• Device-Based Therapy
• Others

By Diagnosis & Management Approach

• Polysomnography & Sleep Studies
• Actigraphy-Based Monitoring
• Clinical Evaluation & Screening Tools
• Remote / Digital Sleep Monitoring Solutions

By Application

• Hospitals
• Home Care Settings
• Others

Asia-Pacific Sleep-Wake Disorder Market Report Segment by Country

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-sleep-wake-disorder-market